pI: 6.0098 |
Length (AA): 216 |
MW (Da): 23376 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_129785)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_00830 | Aminopeptidase ZK353.6 in chromosome III |
Caenorhabditis elegans | CELE_ZK353.6 | Protein LAP-1 |
Drosophila melanogaster | Dmel_CG7340 | granny smith |
Escherichia coli | b2523 | aminopeptidase B |
Homo sapiens | ENSG00000215440 | aminopeptidase-like 1 |
Leishmania braziliensis | LbrM.33.2840 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Leishmania braziliensis | LbrM.11.0410 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Leishmania donovani | LdBPK_332700.1 | metallo-peptidase, Clan MF, Family M17 |
Leishmania infantum | LinJ.33.2700 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Leishmania infantum | LinJ.11.0640 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Leishmania major | LmjF.11.0630 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Leishmania major | LmjF.33.2570 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Leishmania mexicana | LmxM.32.2570 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Leishmania mexicana | LmxM.11.0630 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Loa Loa (eye worm) | LOAG_09171 | aminopeptidase in chromosome III |
Mus musculus | ENSMUSG00000039263 | aminopeptidase-like 1 |
Trypanosoma brucei gambiense | Tbg972.11.2720 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Trypanosoma brucei gambiense | Tbg972.11.7420 | aminopeptidase, putative,metallo-peptidase, Clan MF, Family M17 |
Trypanosoma brucei | Tb11.v5.0360 | aminopeptidase, putative |
Trypanosoma brucei | Tb927.11.6590 | metallo-peptidase, Clan MF, Family M17 |
Trypanosoma brucei | Tb927.11.2470 | metallo-peptidase, Clan MF, Family M17 |
Trypanosoma congolense | TcIL3000_0_35010 | metallo-peptidase, Clan MF, Family M17 |
Trypanosoma cruzi | TcCLB.504153.140 | metallo-peptidase, Clan MF, Family M17 |
Trypanosoma cruzi | TcCLB.508799.240 | metallo-peptidase, Clan MF, Family M17 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.0070 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0070 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0070 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb11.02.0070 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb11.02.4440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.4440 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.4440 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.4440 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2523 | Escherichia coli | non-essential | goodall |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.